175 related articles for article (PubMed ID: 26098768)
1. Historical review of thymosin α 1 in infectious diseases.
Camerini R; Garaci E
Expert Opin Biol Ther; 2015; 15 Suppl 1():S117-27. PubMed ID: 26098768
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis.
Yang YF; Zhao W; Zhong YD; Yang YJ; Shen L; Zhang N; Huang P
Antiviral Res; 2008 Feb; 77(2):136-41. PubMed ID: 18078676
[TBL] [Abstract][Full Text] [Related]
3. Thymosin alpha1: a historical overview.
Garaci E
Ann N Y Acad Sci; 2007 Sep; 1112():14-20. PubMed ID: 17567941
[TBL] [Abstract][Full Text] [Related]
4. Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology era.
Mao L
Int Immunopharmacol; 2023 Apr; 117():109952. PubMed ID: 36871535
[TBL] [Abstract][Full Text] [Related]
5. Thymosin alpha1. SciClone Pharmaceuticals.
Billich A
Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
[TBL] [Abstract][Full Text] [Related]
6. Historical review on thymosin α1 in oncology: preclinical and clinical experiences.
Garaci E; Pica F; Matteucci C; Gaziano R; D'Agostini C; Miele MT; Camerini R; Palamara AT; Favalli C; Mastino A; Serafino A; Sinibaldi Vallebona P
Expert Opin Biol Ther; 2015; 15 Suppl 1():S31-9. PubMed ID: 26096345
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of thymosin alpha1 therapy for chronic hepatitis B patients.
Arase Y; Tsubota A; Suzuki Y; Suzuki F; Kobayashi M; Someya T; Akuta N; Hosaka T; Saitoh S; Ikeda K; Kobayashi M; Kumada H
Intern Med; 2003 Oct; 42(10):941-6. PubMed ID: 14606705
[TBL] [Abstract][Full Text] [Related]
8. Thymalfasin for the treatment of chronic hepatitis B.
Chien RN; Liaw YF
Expert Rev Anti Infect Ther; 2004 Feb; 2(1):9-16. PubMed ID: 15482167
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.
Iino S; Toyota J; Kumada H; Kiyosawa K; Kakumu S; Sata M; Suzuki H; Martins EB
J Viral Hepat; 2005 May; 12(3):300-6. PubMed ID: 15850471
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.
Liu F; Wang HM; Wang T; Zhang YM; Zhu X
BMC Infect Dis; 2016 Sep; 16():488. PubMed ID: 27633969
[TBL] [Abstract][Full Text] [Related]
11. Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis.
Li C; Bo L; Liu Q; Jin F
Int J Infect Dis; 2015 Apr; 33():90-6. PubMed ID: 25532482
[TBL] [Abstract][Full Text] [Related]
12. Thymosin alpha 1 treatment for patients with sepsis.
Pei F; Guan X; Wu J
Expert Opin Biol Ther; 2018 Jul; 18(sup1):71-76. PubMed ID: 30063866
[TBL] [Abstract][Full Text] [Related]
13. Thymosin alpha 1: from bench to bedside.
Garaci E; Favalli C; Pica F; Sinibaldi Vallebona P; Palamara AT; Matteucci C; Pierimarchi P; Serafino A; Mastino A; Bistoni F; Romani L; Rasi G
Ann N Y Acad Sci; 2007 Sep; 1112():225-34. PubMed ID: 17600290
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.
Lee HW; Lee JI; Um SH; Ahn SH; Chang HY; Park YK; Hong SP; Moon YM; Han KH
J Gastroenterol Hepatol; 2008 May; 23(5):729-35. PubMed ID: 18410608
[TBL] [Abstract][Full Text] [Related]
15. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
Loggi E; Gramenzi A; Margotti M; Cursaro C; Galli S; Vitale G; Grandini E; Scuteri A; Vukotic R; Andreone P; Bernardi M
J Viral Hepat; 2008 Jun; 15(6):442-8. PubMed ID: 18221304
[TBL] [Abstract][Full Text] [Related]
16. Clonal growth inhibition as a bioassay for thymosin alpha1: inactivation of Talpha1 by trifluroacetic acid.
Bianco-Batlles D; Naylor CW; Moshier JA; Dosescu J; Naylor PH
Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):157-60. PubMed ID: 11292250
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approach.
Naylor PH; Mutchnick MG
J Viral Hepat; 2018 Jan; 25(1):4-9. PubMed ID: 29052304
[TBL] [Abstract][Full Text] [Related]
18. Generation of mature Nα-terminal acetylated thymosin α 1 by cleavage of recombinant prothymosin α.
Liu B; Gong X; Chang S; Sun P; Wu J
ScientificWorldJournal; 2013; 2013():387282. PubMed ID: 24288480
[TBL] [Abstract][Full Text] [Related]
19. Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application.
Tao N; Xu X; Ying Y; Hu S; Sun Q; Lv G; Gao J
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110771
[TBL] [Abstract][Full Text] [Related]
20. Immunopharmacology of thymosin alpha1 and cytokine synergy.
Naylor PH; Quadrini K; Garaci E; Rasi G; Hadden JW
Ann N Y Acad Sci; 2007 Sep; 1112():235-44. PubMed ID: 17567942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
